Skip to main content

Table 2 Clinical, Laboratory and Imaging characteristics of the groups.

From: New clinical score to diagnose nonalcoholic steatohepatitis in obese patients

  Non-NASH group
AVG (± SD)
NASH group
AVG (± SD)
P
Gender: % women 84.9 76.9 0.503
Age ( years) 39.8 (± 10.4) 44.6 (± 12.5) 0.216*
BMI ( Kg/m2) 46.3 (± 6.45) 47.0 (± 6.72) 0.714
HAS (% positive) 58.5 46.2 0.423
DM (% positive) 13.2 23.1 0.374
CT (mg/dL) 195.4 (± 37.28) 210.2 (± 22.3) 0.094*
LDL (mg/dL) 120 (± 35) 125.8 (± 22) 0.488
TG (mg/dL) 141.3 (± 57.5) 163 (± 111) 0.544
HDL (mg/dL) 49.0 (± 11.9) 48.9 (± 7.9) 0.968
FG (mg/dL) 103.2 (± 23.9) 100.5 (± 11.6) 0.589
AST (IU/L) 23.6 (± 9.2) 31.6 (± 22.4) 0.248*
ALT (IU/L) 24.5 (± 13.1) 44.8 (± 45) 0.151*
GGT (IU/L) 38.2(24.4) 46.5(18.5) 0.229*
AAR 1.000 0.7677 0.047**
ALP (IU/L) 170.2 (± 79.7) 159.6 (± 56.5) 0.659
SM (% positive) 67.4 66.7 0.960
US (% abnormal) 47 77 0.048**
  1. Data is expressed as Mean ± SD (except for AAR that has a non-parametric distribution).